INPP4B suppresses prostate cancer cell invasion.
INPP4B suppresses prostate cancer cell invasion.
复制标题
DOI:
10.1186/s12964-014-0061-y
复制
发表时间:
2014-09-25
期刊:
影响因子:
--
通讯作者:
Agoulnik IU
中科院分区:
文献类型:
--
作者:
Hodgson MC;Deryugina EI;Suarez E;Lopez SM;Lin D;Xue H;Gorlov IP;Wang Y;Agoulnik IU
INPP4B and PTEN dual specificity phosphatases are frequently lost during progression of prostate cancer to metastatic disease. We and others have previously shown that loss of INPP4B expression correlates with poor prognosis in multiple malignancies and with metastatic spread in prostate cancer. We demonstrate that de novo expression of INPP4B in highly invasive human prostate carcinoma PC-3 cells suppresses their invasion both in vitro and in vivo. Using global gene expression analysis, we found that INPP4B regulates a number of genes associated with cell adhesion, the extracellular matrix, and the cytoskeleton. Importantly, de novo expressed INPP4B suppressed the proinflammatory chemokine IL-8 and induced PAK6. These genes were regulated in a reciprocal manner following downregulation of INPP4B in the independently derived INPP4B-positive LNCaP prostate cancer cell line. Inhibition of PI3K/Akt pathway, which is highly active in both PC-3 and LNCaP cells, did not reproduce INPP4B mediated suppression of IL-8 mRNA expression in either cell type. In contrast, inhibition of PKC signaling phenocopied INPP4B-mediated inhibitory effect on IL-8 in either prostate cancer cell line. In PC-3 cells, INPP4B overexpression caused a decline in the level of metastases associated BIRC5 protein, phosphorylation of PKC, and expression of the common PKC and IL-8 downstream target, COX-2. Reciprocally, COX-2 expression was increased in LNCaP cells following depletion of endogenous INPP4B. Taken together, we discovered that INPP4B is a novel suppressor of oncogenic PKC signaling, further emphasizing the role of INPP4B in maintaining normal physiology of the prostate epithelium and suppressing metastatic potential of prostate tumors. The online version of this article (doi:10.1186/s12964-014-0061-y) contains supplementary material, which is available to authorized users.
登录
查看更多内容
DOI:
10.1158/1078-0432.ccr-09-0911
发表时间:
2009-09-15
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Arredouani MS;Lu B;Bhasin M;Eljanne M;Yue W;Mosquera JM;Bubley GJ;Li V;Rubin MA;Libermann TA;Sanda MG
通讯作者:
Sanda MG
影响因子:
4.8
作者:
Bekes, Erin M.;Deryugina, Elena I.;Quigley, James P.
通讯作者:
Quigley, James P.
影响因子:
50.3
作者:
Gewinner C;Wang ZC;Richardson A;Teruya-Feldstein J;Etemadmoghadam D;Bowtell D;Barretina J;Lin WM;Rameh L;Salmena L;Pandolfi PP;Cantley LC
通讯作者:
Cantley LC
DOI:
10.4049/jimmunol.1201529
发表时间:
2012-10-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Kwek SS;Dao V;Roy R;Hou Y;Alajajian D;Simko JP;Small EJ;Fong L
通讯作者:
Fong L
影响因子:
6.4
作者:
Lang, K;Niggemann, B;Entschladen, F
通讯作者:
Entschladen, F